Vitamin A Status and Risk of Excessive Vitamin A Intake Among Urban Filipino Children
- Conditions
- Vitamin A Status
- Interventions
- Other: High VA intake, recent VASOther: High VA intakeOther: Low/adequate VA intake
- Registration Number
- NCT03030339
- Lead Sponsor
- University of California, Davis
- Brief Summary
The goal of this study is to assess whether children 12-18 months of age who are exposed to multiple large-scale vitamin A programs, and who are likely to have vitamin A intakes above the tolerable upper intake level (UL), have higher total body vitamin A stores and biomarkers of excessive vitamin A status, compared to children 12-18 months of age who have adequate vitamin A intake.
- Detailed Description
This is an observational study with 3 groups, which are identified using a screening tool to obtain information on exposure to vitamin A programs and consumption of vitamin A-rich foods and supplements. Children and their mothers are studied over the course of one month to determine 1) child total body vitamin A stores, using the 13C retinol isotope dilution method, 2) the child's vitamin A intake, using multiple dietary assessment methods, 3) total breast milk intake (among breastfeeding children), using the dose-to-mother deuterium dilution method, and 4) potential biomarkers of excessive vitamin A status, including markers of bone and liver health. Blood collection is structured in a "Super-Child" design, to construct plasma retinol kinetic curves. Other indicators related to vitamin A nutrition among children will be measured, in addition to the vitamin A intake and breast milk vitamin A concentration (for breastfeeding mothers) of the mother.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 123
- Children 12-18 months of age, and their mothers (18-49 years of age)
- Living in selected communities in the National Capital Region of the Philippines
- The mother and child must plan to stay in the study area for the duration of the study.
- Child's estimated vitamin A intake and exposure to vitamin A programs must meet eligibility criteria for one of three groups, based on a screening questionnaire administered by an interviewer to the child's mother.
Eligibility criteria for children in Group 1: 1) consumed MNP or a multi-vitamin preparation that contains vitamin A in the previous 7 days, 2) consumed at least one fortified staple food (oil or wheat flour) in the previous 7 days, 3) consumed breast milk or fortified milk in the past 24 hours, 4) received a high-dose VA capsule during the previous month, and 5) received a screening tool 'score' suggesting VA intake above 600 µg retinol/d.
Eligibility criteria for children in Group 2: will include children who: 1) consumed MNP or a multi-vitamin A preparation that contains vitamin A in the previous 7 days, 2) consumed at least one fortified staple food (oil or wheat flour) in the previous 7 days, 3) consumed breast milk or fortified milk in the past 24 hours, 4) received a high-dose VA capsule in the previous 3-6 months, and 5) received a screening tool 'score' suggesting VA intake above 600 µg retinol/d.
Eligibility criteria for children in Group 3: will include children who: 1) received a high dose VA capsule during the previous 3-6 months, and 2) received a screening tool 'score' suggesting VA intake 200-500 µg/d.
- The child did not receive a high-dose VA capsule during the most recent national campaign
- The mother or child has chronic disease
- The child has moderate or severe anemia (Hb <10 g/dL)
- The mother or child has signs or symptoms of vitamin A deficiency (Bitot's spots, conjunctival xerosis, nightblindness)
- The child has weight for length < -2 z-scores of the median of the WHO growth standards
- The mother is breastfeeding more than one child
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Group 1: High VA intake, recent VAS High VA intake, recent VAS Children who are exposed to multiple vitamin A (VA) programs, have received a high-dose VA supplement (VAS; 200,000 IU) in the past month, and are identified as being likely to have chronic excessive dietary VA intake Group 2: High VA intake High VA intake Children who are exposed to multiple vitamin A (VA) programs, have received a high-dose VA supplement (200,000 IU) in the past 3-6 months, and are identified as being likely to have chronic excessive dietary VA intake. Group 3: Low/adequate VA intake Low/adequate VA intake Children who are not exposed to multiple vitamin A (VA) programs, have received a high-dose VA supplement in the past 3-6 months, and are identified as being likely to have chronic low to adequate dietary VA intake.
- Primary Outcome Measures
Name Time Method Total dietary vitamin A intake among children 12-18 mo of age 28-day study period Estimated using 24-hour dietary recalls, observed weighed food records, food and supplement frequency questionnaire, breast milk vitamin A concentration, and total breast milk intake (measured by the dose-to-mother deuterium dilution technique)
Total breast milk intake (among breastfeeding children 12-18 mo of age) 15-day study period Estimating using the dose-to-mother deuterium dilution technique.
Total body vitamin A stores among children 12-18 mo of age 28-day study period Estimated using the 13C-retinol dilution method
- Secondary Outcome Measures
Name Time Method Liver function markers among children 12-18 mo of age 28-day study period Consumption of fortifiable foods among women 28 day study period Estimated by combining data from 24-hour recalls, observed weighed food records, food frequency questionnaires, and the Fortification Assessment Coverage Tool
Plasma or serum retinol-binding protein among children 12-18 mo of age 28-day study period Total vitamin A intake among women 28-day study period Estimated using 24-hour dietary recalls and food frequency questionnaires
Consumption of fortifiable foods among children 28 day study period Estimated by combining data from 24-hour recalls, observed weighed food records, food frequency questionnaires, and the Fortification Assessment Coverage Tool
Transthyretin among children 12-18 mo of age 28-day study period Retinol metabolites among children 12-18 mo of age 28-day study period Plasma or serum retinol among children 12-18 mo of age 28-day study period Ratio of retinol to retinol-binding protein among children 12-18 mo of age 28-day study period Bone health markers among children 12-18 mo of age 28-day study period Breast milk vitamin A concentration among lactating women 28-day study period
Trial Locations
- Locations (1)
Block 37 Health Center
🇵🇭Mandaluyong, National Capital Region, Philippines